As KCC2 and NKCC1 have previously been implicated in altering GABA signaling polarity in neurological disorders such as HD, there is speculation that a similar mechanism is contributing to disease progression in AD [8,63]. This evidence concerns the gene SLC12A5 and Alzheimer disease.